Systematic Analysis of the Pharmacology of Standardized Extracts of Human Placenta
January 2024
in “
Pharmacokinetics and Pharmacodynamics
”
Studysummary This review discusses peptide "biogenic stimulants" from human placenta extracts, highlighting their potential wide-ranging clinical applications across multiple diseases, and reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study explores the pharmacological potential of human placenta extracts (HPE) as "biogenic stimulants" for various diseases, building on initial research from the 1930s. Utilizing modern postgenomic pharmacology techniques, such as mass spectrometry and sequencing, researchers have identified the molecular mechanisms of peptide extracts. Clinical studies of standardized extracts reveal their potential applications in treating liver diseases, viral infections like COVID-19, conditions with iron overload, chronic fatigue syndrome, skin diseases, joint pathologies, wound healing, and female reproductive system disorders.
